The increased sensitivity of immunofixation electrophoresis (IFE) over prior electrophoretic methods has led to renewed interest in the study of free light chains. Here, we discuss problems associated with the identification of monoclonal free light chains (Bence Jones proteins) in urine. Besides reviewing the nature of the sample specimens and the assays themselves, we discuss the physiology, biochemistry, genetics, and immunological properties of these molecules. Direct measurement of ijA ratios may ultimately be useful, but all commercial methods available now lack sufficient sensitivity. IFE is the prererred method because of its sensitivityand ease of interpretation. There are, however, difficultiesassociated with the interpretation of urinary IFE patterns, because the technique does not include an intrinsic mechanism for antibody-antigen titration and because of its great sensitivity in the absence of quantification. Problems of interpretation are discussed.
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Indexing Terms: Bence Jones proteins/iilA rafio/immunoelectrophoresis/plasma cell dyscrasia/renai disease/amyloidosis/multiple rnyeloma/monoc!ona! gammopathy Edelman and Gaily (1) demonstrated that tight chains of immunoglobulins were identical to the protein discovered by Henry Bence Jones in the urine of a patient with multiple myeloma more than 100 years earlier (2). This observation linked the production of monoclonal free light chains to this disease. Subsequently, it was shown that monoclonal free light chains can cause disease as a result of amyloid (3) and nonamyloid fibril deposition (4).
In 1962
Free light chains are normally produced and secreted by plasma cells (5) (6) (7) , and polyclonal free light chains are normally found in serum and urine (7, 8 tiple myeloma and other plasma cell dyscrasias, free light chains are also associated with other abnormalities of the immune system, including leukemia, lymphoma, and autoimmune and infectious diseases (9,10). Analysis by IFE indicates that polyclonal free light chains may migrate as multiple small bands, ladderlike patterns that may be mistaken for monoclonal bands (11-13).
The purpose of this report is to discuss problems associated with the identification of monoclonal free light chains (Bence Jones proteins) in clinical laboratories. To best appreciate these problems, one must understand the physiological, biochemical, and immunological properties of these molecules, as well as the techniques used to identify them. For this reason, besides reviewing the assays themselves and the nature of the sample specimens, we discuss the structure, synthesis, excretion, and pathology of immunoglobulin light chains; assays used for identification;
and immunological peculiarities associated with measurement.
Structure and Synthesis of Ught Chains
Immunoglobulin monomers are composed of two identical heavy and two identical light polypeptide chains linked by disulfide bonds, with an overall molecular mass of -150 kDa (Fig. 1) . Because the C-terminal portion of the heavy chain is responsible for the biological capabilities of the molecule, the heavy chains define the immunoglobulin classes and subclasses. The light chains, K and A, are common to immunoglobulins of all classes. IgG, IgA, and 1gM comprise the majority of the immunoglobulins found in blood. IgG is usually found as a monomer that sediments in a density gradient at 7S, whereas 1gM is normally found as a pentamer, five 150-kfla units attached by disulfide bonds (molecular mass -800 kDa), and sediments at 19S. IgA may be found as a monomer in blood or as a dimer in secretions, with carbohydrate moiety normally attached only to the heavy chain. Each monomeric antibody consists of a constant (Fc) and variable (Fab) end (Fig. 1) . The Fab end contains the variable region with the antigen-combining site (paratope); the Fe portion binds to plasma proteins, such as complement and fibronectin, and cell Fe receptors and contains the heavychain class determinants.
Similarly, the C-terminal half of the light chain is the constant region, which provides the K or A antigenic characteristics, and the N-terminal half of the light chain is the variable region, which has antigen-binding capability. The human K light-chain genome is located on chromosome 2, and the A genome on chromosome 22. The variable region is encoded by two sets of genes, V (variable) and J (joining), and the constant region by C genes. There are multiple V genes. As illustrated in Fig. 2 , there are five tandemly arranged aJ gene segments followed by one C gene. There are six AJ genes and six virtually identical C genes, two of which are nonfunctional (pseudogenes) (19) . Each AC gene is preceded by a separate J gene. The V gene encodes the first 95-98 amino acid residues of the variable region and the J gene the next 12 K or 13 A (Fig. 1) (14) . Besides the V (29) . Data suggest that the myeloma cells have gone through stages of somatic mutation and antigen selection (30). This may explain why the major isotypes of the paraproteins are mainly IgG or IgA, and are rarely 1gM (30), which is more commonly associated with lymphoma and Waldenstr#{246}m macroglobulinemia.
The median age at diagnosis of myeloma is 64 years; the disease is rare in those <40 years. Most patients with multiple myeloma exhibit >10% plasma cells in bone marrow (normally <4% plasma cells), a M-component in serum or urine (>95% of patients), and lytic bone lesions (-60% of patients) with pain and fracture (31, 32). One or more of these diagnostic features may be difficult to document. Primary amyloidosis (AL), which was thought to involve the heart, gastrointestinal tract, tongue, nerves, and skin (43), has been shown to contain fibrils composed of immunoglobulin light chains (3,45). Secondary amyloidosis was characterized by an involvement of the liver, spleen, and kidney, along with an associated inflammatory disorder of long standing such as rheumatoid arthritis, chronic infection, and familial Mediterranean fever (42) (43) (44) (45) (46) . It is now known that neither AL nor secondary amyloidosis is limited to specific organs, and that both involve nerves, liver, gastrointestinal tract, heart, and kidney; kidney involvement is the most frequent initial manifestation of both types (42) (43) (44) (45) (46) A small increase in serum concentrations must not be dismissed as a MGUS until the clinician has excluded the possibility of amyloidosis.
3) Light-chain deposition in tissues may take a form that is less structured than ainyloid, and that does not exhibit apple-green birefringence upon polarized light examination of Congo Red-stained sections (48). With the advent of immunofluorescence histological techniques, LCDD is being recognized more and more frequently (31). In contrast to AL, in which the light chains are most often A, K is the most commonly found in LCDD, which may affect the kidney, heart, liver, gasbrointestinal tract, skin, and blood vessels. (54) . The strips are more sensitive to albumin than to globulin, whereas the confirmatory methods measure both albumin and globulin to various degrees. The degree to which these methods measure free light chains is unclear. Very few laboratories use the biuret method, which reacts with the peptide bonds in proteins, thereby measuring all proteins equally. As a result, except for biuret, these methods cannot be relied upon to provide useful information regarding quantitation of free light chains, although a mildly positive or negative result by dip-strip analysis followed by a grossly positive confirmatory result may indicate the presence of an unsuspected Bence Jones protein (55, 56) . However, the sensitivity of the biuret method is less than that of IFE.
Identification of Ught Chains In UrIne
Thus, we consider these protein assays to be made- 
#{247} [IgGI

Total protein (TCA method)
This is followed by a second step in which a WA ratio is calculated after immunochemical analysis of samples showing an excess of total protein (>31%). Boege et al. assume that those with WA ratios between a reference range of 1.0 and 5.2 do not contain a Bence Jones protein, while those with ratios greater or less than the reference range do (65). Since the first step relies on the difference between total protein and measured proteins to identify suspect samples, it presumes that all Bence Jones proteins are precipitated by the TCA reagent. Nevertheless, in a small study with 40 myeloma patients and 69 patients with proteinuria unrelated to plasma cell dyscrasia, this approach showed a sensitivity and specificity equal to that of IFE. However, quantification of the components for this assay is itself costly, and the assays, together with the calculations, introduce many sources for potential errors. Also, commercial light-scatter assays are limited by analytical sensitivity in the low range. End-point techniques can measure down to -5 mgfL, whereas rate nephelometry is 5-to 10-fold less sensitive.
Others have compared the WA ratio in serum with the WA ratio in urine (WA index). A difference between the ratios of more than threefold suggests Bence Jones protein (61, 65). Unfortunately, because of the lack of analytical sensitivity of automated analyzers, the WAratio could not be determined in many urines (because either the ,c or A concentration or both are below the detection limit). Again, the study was small and only a limited number of specimens was examined. (Fig. 4) , is more often associated with K, but may also be found upon analysis of A light chains, and can be uncovered in most urine specimens with proteinuria if the concentration is sufficiently titrated (12, 13, 17) . It was demonstrated that this pattern is the property of normal free light chains by inducing the transient appearance of multiple K bands with arginine infusion in healthy volunteers (13). The multiple banding pattern appears to be largely a product of charge differences (12, 13, 17). Although this pattern may resemble an "oligoclonal pattern," we prefer to restrict the usage of that term to multiple bands seen in serum and cerebrospinal fluid, which are very likely clonal products. In this review, we have avoided the use of this term because it is possible that the bands in urine reflect families of light chains with similar mobilities-not necessarily clonal products. Thus, until further definitive evidence is available, we will continue to refer to the urinary polyclonal banding pattern as multiple bands or ladder pattern. The pattern may be related to constraints on the final number of amino acids (107 variable half-residues and 107 CK or 105 CA) and constraints on the framework regions along with genetic recombination in the hypervariable regions. This might give rise to similar overall structure yet allow for charge differences that might produce fam- This work was supported in part by funding from the Department of Veteran Affairs.
